Tesi Raymond Joseph 4
4 · Inmune Bio, Inc. · Filed May 16, 2024
Insider Transaction Report
Form 4
Inmune Bio, Inc.INMB
Tesi Raymond Joseph
DirectorPresident & CEO10% Owner
Transactions
- Award
Option (right to buy)
2024-05-14+160,000→ 160,000 totalExercise: $9.92Exp: 2034-05-13→ Common Stock (160,000 underlying)
Footnotes (1)
- [F1]Granted pursuant to the 2021 Stock Incentive Plan. One fourth (1/4) of the option will vest 12 months from the grant date and thereafter the remaining unvested option will become vested and exercisable on a monthly basis over three (3) years (1/36 per month) until the option is 100% vested which shall occur on the four-year anniversary of the grant date.